Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis

Cell Cycle

Volumn 11, Issue 12, 2012, Pages 2348-2358

  Li, Weihua ^a,b   Tai, Yanhong ^c   Zhou, Jie ^b,d   Gu, Weiting ^a,b   Bai, Zhaofang ^e   Zhou, Tao ^e   Zhong, Zhijiu ^b   McCue, Peter A ^f   Sang, Nianli ^g   Ji, Jun Yuan ^h   Kong, Beihua ^a   Jiang, Jie ^a   Wang, Chenguang ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c 90th Hospital of Jinan   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

^f THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^g DREXEL UNIVERSITY   (United States)

^h TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Cell death; Cell growth; Endometrial cancer; Lipogenesis; SREBP1

Indexed keywords

STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CELLULAR DISTRIBUTION; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPOGENESIS; TUMOR GROWTH;

EID: 84862837453     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.20811     Document Type: Article

References (51)

1. Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 1995; 25:667-73; PMID:7759101; http://dx.doi.org/10.1016/0888-7543(95)80009-B.
2. Edwards PA, Tabor D, Kast HR, Venkateswaran A. Regulation of gene expression by SREBP and SCAP. Biochim Biophys Acta 2000; 1529:103-13; PMID:11111080.
3. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994; 77:53-62; PMID:8156598; http://dx.doi. org/10.1016/0092-8674(94)90234-8.
4. Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, et al. SREBP-2, a second basichelix- loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 1993; 90:11603- 7; PMID:7903453; http://dx.doi.org/10.1073/pnas.90.24.11603.
5. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993; 75:187- 97; PMID:8402897.
6. Briggs MR, Yokoyama C, Wang X, Brown MS, Goldstein JL. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 1993; 268:14490-6; PMID:8390995.
7. Wang X, Briggs MR, Hua X, Yokoyama C, Goldstein JL, Brown MS. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J Biol Chem 1993; 268:14497-504; PMID:8314806.
8. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001; 40:439-52; PMID:11591434; http://dx.doi.org/10.1016/S0163-7827(01)00010-8.
9. Horton JD, Shimomura I. Sterol regulatory element- binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 1999; 10:143-50; PMID:10327282; http://dx.doi.org/10.1097/00041433-199904000-00008.
10. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006; 9:358- 65; PMID:16778563; http://dx.doi.org/10.1097/01.mco.0000232894.28674.30.
11. Yang YA, Morin PJ, Han WF, Chen T, Bornman DM, Gabrielson EW, et al. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res 2003; 282:132-7; PMID:12531699; http://dx.doi.org/10.1016/S0014-4827(02)00023-X.
12. Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME, et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 2004; 64:2212-21; PMID:15026365; http://dx.doi.org/10.1158/0008-5472.CAN- 2148-2.
13. Yahagi N, Shimano H, Hasegawa K, Ohashi K, Matsuzaka T, Najima Y, et al. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 2005; 41:1316-22; PMID:15869874; http://dx.doi.org/10.1016/j.ejca.2004. 12.037.
14. Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, et al. Increased lipogenesis, induced by AKTmTORC1- RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 2011; 140:1071-83; PMID:21147110; http://dx.doi.org/10.1053/j.gastro.2010.12.006.
15. Yamashita T, Honda M, Takatori H, Nishino R, Minato H, Takamura H, et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009; 50:100-10; PMID:19008011; http://dx.doi.org/10.1016/j.jhep.2008.07.036.
16. Li JN, Mahmoud MA, Han WF, Ripple M, Pizer ES. Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp Cell Res 2000; 261:159- 65; PMID:11082286; http://dx.doi.org/10.1006/excr.2000.5054.
17. Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, et al. Fatty acid synthase gene is upregulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 2008; 68:1003-11; PMID:18281474; http://dx.doi.org/10.1158/0008-5472.CAN-07-2489.
18. Yoon S, Lee MY, Park SW, Moon JS, Koh YK, Ahn YH, et al. Upregulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J Biol Chem 2007; 282:26122- 31; PMID:17631500; http://dx.doi.org/10.1074/jbc.M702854200.
19. Yang YA, Han WF, Morin PJ, Chrest FJ, Pizer ES. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol-3-kinase. Exp Cell Res 2002; 279:80-90; PMID:12213216; http://dx.doi.org/10.1006/excr.2002.5600.
20. Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 1998; 95:4333-7; PMID:9539737; http://dx.doi.org/10.1073/pnas.95.8.4333.
21. Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996; 10:1096- 107; PMID:8654925; http://dx.doi.org/10.1101/gad.10.9.1096.
22. Lupu R, Menendez JA. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators? Endocrinology 2006; 147:4056-66; PMID:16809439; http://dx.doi.org/10.1210/en. 2006-0486.
23. Tsuji T, Yoshinaga M, Togami S, Douchi T, Nagata Y. Fatty acid synthase expression and clinicopathological findings in endometrial cancer. Acta Obstet Gynecol Scand 2004; 83:586-90; PMID:15144342.
24. Yin C, Qie S, Sang N. Carbon source metabolism and its regulation in cancer cells. Crit Rev Eukaryot Gene Expr 2012; 22:17-35; PMID:22339657.
25. Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 1998; 101:1-9; PMID:9421459; http://dx.doi.org/10.1172/JCI1411.
26. Chen G, Liang G, Ou J, Goldstein JL, Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci USA 2004; 101:11245-50; PMID:15266058; http://dx.doi.org/10.1073/pnas.0404297101.
27. Walker AK, Yang F, Jiang K, Ji JY, Watts JL, Purushotham A, et al. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 2010; 24:1403- 17; PMID:20595232; http://dx.doi.org/10.1101/gad.1901210.
28. Eberhard Y, Gronda M, Hurren R, Datti A, MacLean N, Ketela T, et al. Inhibition of SREBP1 sensitizes cells to death ligands. Oncotarget 2011; 2:186-96; PMID:21406729.
29. Lao T, Chen S, Sang N. Two mutations impair the stability and function of ubiquitin-activating enzyme (E1). J Cell Physiol 2012; 227:1561-8; PMID:21678405; http://dx.doi.org/10.1002/jcp.22870.
30. Tontonoz P, Kim JB, Graves RA, Spiegelman BM. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993; 13:4753-9; PMID:8336713.
31. Migita T, Narita T, Nomura K, Miyagi E, Inazuka F, Matsuura M, et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res 2008; 68:8547-54; PMID:18922930; http://dx.doi.org/10.1158/ 0008-5472.CAN-08-1235.
32. Zu XY, Zhang QH, Liu JH, Cao RX, Zhong J, Yi GH, et al. ATP citrate lyase inhibitors as novel cancer therapeutic agents. Recent Pat Anticancer Drug Discov 2012; 7:154-67; PMID:22339355; http://dx.doi.org/10.2174/ 157489212799972954.
33. Luo DX, Tong DJ, Rajput S, Wang C, Liao DF, Cao D, et al. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential. Recent Pat Anticancer Drug Discov 2012; 7:168-84; PMID:22339356; http://dx.doi. org/10.2174/157489212799972918.
34. Wang C, Rajput S, Watabe K, Liao DF, Cao D. Acetyl- CoA carboxylase-a as a novel target for cancer therapy. [Schol Ed]. Front Biosci (Schol Ed) 2010; 2:515-26; PMID:20036965; http://dx.doi.org/10.2741/s82.
35. Tong L, Harwood HJ Jr. Acetyl-coenzyme A carboxylases: versatile targets for drug discovery. J Cell Biochem 2006; 99:1476-88; PMID:16983687; http://dx.doi.org/10.1002/jcb.21077.
36. Roongta UV, Pabalan JG, Wang X, Ryseck RP, Fargnoli J, Henley BJ, et al. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res 2011; 9:1551-61; PMID:21954435; http://dx.doi.org/10.1158/1541-7786.MCR-11-0126.
37. Kim SJ, Choi H, Park SS, Chang C, Kim E. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation. Mol Cells 2011; 31:371-7; PMID:21331774; http://dx.doi.org/10.1007/s10059-011-0043-5.
38. Minville-Walz M, Pierre AS, Pichon L, Bellenger S, Fèvre C, Bellenger J, et al. Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLoS One 2010; 5:14363; PMID:21179554; http://dx.doi.org/10.1371/journal.pone.0014363.
39. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010; 31:1509-15; PMID:20595235; http://dx.doi.org/10.1093/ carcin/bgq131.
40. Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 2010; 9:1740-54; PMID:20530718; http://dx.doi.org/10.1158/ 1535-7163.MCT-09-1064.
41. Liu H, Liu JY, Wu X, Zhang JT. Biochemistry, molecular biology and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Biol 2010; 1:69-89; PMID:20706604.
42. Vainio P, Lehtinen L, Mirtti T, Hilvo M, Seppänen- Laakso T, Virtanen J, et al. Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins. Oncotarget 2011; 2:1176-90;PMID:22202492.
43. Bratos K, Roszak A, Cikowska-Wozniak E, Niecewicz P. Analysis of epidemiologic risk factors for endometrial cancer. Ginekol Pol 2002; 73:945-50; PMID:12722379.
44. Gull B, Karlsson B, Milsom I, Granberg S. Factors associated with endometrial thickness and uterine size in a random sample of postmenopausal women. Am J Obstet Gynecol 2001; 185:386-91; PMID:11518897; http://dx.doi.org/ 10.1067/mob.2001.115869.
45. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11:185-92; PMID:10710204; http://dx.doi.org/10.1023/A:1008946825313.
46. Shoff SM, Newcomb PA. Diabetes, body size and risk of endometrial cancer. Am J Epidemiol 1998; 148:234- 40; PMID:9690359; http://dx.doi.org/10.1093/ oxfordjournals.aje.a009630.
47. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, et al. Diet, body size, physical activity and the risk of endometrial cancer. Cancer Res 1997; 57:5077-85; PMID:9371506.
48. Chu K, Miyazaki M, Man WC, Ntambi JM. Stearoylcoenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma highdensity lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol 2006; 26:6786- 98; PMID:16943421; http://dx.doi.org/10.1128/MCB.00077- 06.
49. Toth JI, Datta S, Athanikar JN, Freedman LP, Osborne TF. Selective coactivator interactions in gene activation by SREBP-1a and -1c. Mol Cell Biol 2004; 24:8288- 300; PMID:15340088; http://dx.doi.org/10.1128/MCB.24.18.8288-300. 2004.
50. Amemiya-Kudo M, Shimano H, Yoshikawa T, Yahagi N, Hasty AH, Okazaki H, et al. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J Biol Chem 2000; 275:31078- 85; PMID:10918064; http://dx.doi.org/10. 1074/jbc.M005353200.
51. Zhou J, Zhang W, Liang B, Casimiro MC, Whitaker- Menezes D, Wang M, et al. PPARgamma activation induces autophagy in breast cancer cells. Int J Biochem Cell Biol 2009; 41:2334-42; PMID:19563910; http:// dx.doi.org/10.1016/j.biocel. 2009.06.007.